NCT02727673
Completed
Not Applicable
A Prospective Randomized Trial on the Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer Stem Cells
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Enrollment
- 1000
- Locations
- 1
- Primary Endpoint
- the overall survival rate of each group
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The aim of this study is to establish a platform of detecting and sorting circulating tumor stem cells from peripheral blood in HCC patients; to investigate the relationship between circulating tumor stem cells and their effects on postoperative recurrence and metastasis, in order to provide a new therapeutic target for hepatocellular carcinoma treatment.
Investigators
ShenFeng
vice president of the Eastern Hepatobiliary Surgery Hospital
Eastern Hepatobiliary Surgery Hospital
Eligibility Criteria
Inclusion Criteria
- •Male or female patients \> 18 years and \<=70 years of age;
- •No dysfunction in major organs; Blood routine, kidney function, cardiac function and lung function are basically normal.
- •Patients who can understand this trial and have signed information consent
Exclusion Criteria
- •Reject to attend；
- •Impossible to come to our hospital for physical examination regularly;
- •Patients with other diseases which may affect the treatment mentioned
Outcomes
Primary Outcomes
the overall survival rate of each group
Time Frame: 3 years
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in ImmunotherapyCTC and Tumor Related Rare CellNCT03434912MiCareo Taiwan Co., Ltd.80
Completed
Not Applicable
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell CarcinomaRenal Cell CarcinomaNCT01173445University of Kansas19
Not yet recruiting
Not Applicable
Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell CarcinomaMerkel Cell CarcinomaNCT06448611University Hospital, Montpellier25
Completed
Phase 3
Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)Bone Marrow TransplantationCytomegalovirusNCT00330018Hadassah Medical Organization40
Completed
Not Applicable
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ SystemLung CancerLung NeoplasmsCancer of LungCancer of the LungNeoplasms, LungNeoplasms, PulmonaryPulmonary CancerPulmonary NeoplasmsCarcinoma, Non-small-cell LungAdenocarcinomaSquamous Cell CarcinomaNCT02370303Mayo Clinic23